BDNF and neurodegenerative disease: Transactivation elicited by GPCR ligands can produce neuroprotective effects, such as increased survival of PACAP-treated basal forebrain cholinergic neurons after axotomy (Takei et al., 2000), providing a method for increasing neurotrophin signaling in neurodegenerative diseases.